Конгресс «Право на здоровье»
20 october 2022



RIGHT TO HEALTH is a congress where the pharmaceutical and health care business will answer the most urgent question of our time: How to overcome obstacles and find new opportunities amid sanctions?


The goal of RIGHT TO HEALTH Congress is to provide the possibility to exchange opinions not only among all the Russian parties involved, but also with their potential partners. At the event, industry representatives will be able to share their vision of the current situation, its problems and opportunities, as well as suggestions for developing the healthcare system. What can the business community do to develop the health care system now? How can business and government cooperate more effectively? How can business help protect Russian patients’ right to health? These and many other questions will be raised during the Congress. ONLY SYNERGY OF EFFORTS OF ALL THE PARTIES OF INDUSTRY WILL BRING DOMESTIC HEALTHCARE TO THE NEW QUALITY LEVEL.

Скачать презентацию


The sanctions imposed on the Russian Federation in 2022 placed the domestic health care system in a new reality. The geopolitical situation disrupted finetuned industry processes and tools, primarily supply chains. As a result, the pharmaceutical and healthcare industry in Russia are facing a shortage or lack of medicines and medical devices, and important ingredients for manufacturing pharmaceutical products. Issues of the domestic healthcare industry’ future as a whole have taken on new urgency: for example, whether it would be possible to supply a wide range of medicines in a self-sufficient way, issues of developing scientific potential, efficient and effective business structures, of the compulsory health insurance viability, and the ability to resist external turbulence.

Программа мероприятия

День 1

The Great Hall
Small Hall
Closed meeting room
Lecture Hall 1
9:30 – 10:00

Welcome coffee break, registration

10:00 – 11:30
The Great Hall

New strategy for dealing with socially significant diseases: a multidisciplinary approach and cooperation with business

  • Coordination of efforts among regulators, doctors and manufacturers of medicines and medical devices, including within the framework of the Pharma 2030 program.
  • Attraction of additional budgetary sources for realization of state programmes for socially significant diseases.
  • Analysis of regional best practices in the fight against socially significant diseases.
10:00 – 11:30
Small Hall

Challenges of the commercial medicine market

  • Market transformation under sanctions.
  • Prospects for the transition from licensing of health care facilities to individual licensing individual licensing doctors.
  • The possibility of experimenting with individual licensing of doctors in selected segments of health services.
  • Personal liability and doctors’ insurance.
  • Transformation of the procurement system in the case of the introduction of individual licensing of doctors.
10:00 – 11:30
Closed meeting room

Is there a place for innovation in the new realities?

  • Is the country ready for innovation in terms of technology, clinical trials, market access and exports?
  • The role of the state in innovations.
  • Is the regulator ready for innovation?
10:00 – 11:30
Lecture Hall 1

Regulation of the circulation of medical devices: how does the industry assess it?

  • Assessment of current issues in the regulatory environment of the industry.
  • Amendments to Eurasian Economic Commission and Russian Federation legislation in 2022: their role and initial results.
  • The current situation as the need to update approaches to market regulation.
11:30 – 11:50

Coffee break

11:50 – 13:20
The Great Hall

Reorganization of the endocrinology service in Russia

  • Increasing endo-awareness in primary care.
  • Endocrinological literacy and diabetes schools.
  • Effective routing of patients with endocrinological diseases.
  • The personnel issue in endocrinology. New educational programmes for doctors.
  • Establishment of a federal programme to deal with endocrinological diseases.
11:50 – 13:20
Small Hall

Orphan diseases: financing and procuring in 2022

  • «Kindness circle»: Industry perspective.
  • Financing channels of orphan diseases’ treatment: do we have enough of them.
  • Everyone matters: patients registries, screening programs etc. – how the state and business could cooperate for increasing of diseases’ reveal? How shall be linked detectability with budget expenditure’ control?
11:50 – 13:20
Closed meeting room

Clinical trials in Russia.

  • How has the clinical research landscape changed in 2022?
  • Could Russian clinical base become a center of attraction of regional importance?
  • What issues do Russian clinical trials centers face?
  • The state and prospects of development of the institute of clinical approbation.
  • Is the current regulatory framework sufficient for further development of the clinical trials market? The state and prospects of development of the institute of clinical approbation.
11:50 – 13:20
Lecture Hall 1

Public-private partnership (PPP) in healthcare: science and industry

  • PPP in healthcare: current situation and need for a change.
  • Creating scientific facilities.
  • Business capabilities in commercialization of public research institutions’ development.
13:20 – 13:40

Coffee break

13:40 – 15:10
The Great Hall

National building: developing import substitution

  • Does the industry need new regulations to speed up import substitution?
  • Developing the institutions of the special investment contract, investment protection and promotion agreement, and offset contracts.
  • How the development plan of industrial production will be shaped in healthcare industry?
13:40 – 15:10
Small Hall

Risk sharing. Reimbursement system as an effective approach to medicines supply management

  • International experience: models applied in different countries.
  • Financial burden or economic benefit for the state?
  • Prerequisites for the implementation of successfully functioning medicines reimbursement system in Russia; possible models.
13:40 – 15:10
Closed meeting room

Help together!

  • The role of nonprofit organizationsin Russian healthcare.
  • The current state of charity infrastructure.
  • What is needed for creating a culture of personal involvement in care among the broader population?
13:40 – 15:10
Lecture Hall 1

Veterinary medicines circulation:
transition to the unified market

  • Current state of veterinary medicines market regulation: issues of mutual recognition of national registrations and problems of certification of foreign sites.
  • The adequacy of support measures for veterinary producers.
  • Perspectives and challenges for veterinary medicines manufacturers during the transition period to the unified market of EAEU.
  • Biological safety: industry’ contribution to the further development of the field.
15:10 – 16:00


16:00 – 17:30
The Great Hall

Regulation of coronary stents market in Russia. How to ensure the quality of production and circulation of socially significant medical devices?

  • Market transformation in terms of reduction in supply of coronary stents from foreign manufacturers.
  • Control for distribution and supply chains of coronary stents, implementation of GDP (Good Distribution Practice) standards.
  • Regulation of prices for coronary stents.
  • Support measures needed for Russian stents manufacturers, possibilities of interaction with the government.
16:00 – 17:30
Small Hall

Regulation of the circulation of medicines: how does the industry assess it?

  • Assessment of the regulatory environment in the pharmaceutical industry.
  • Amendments to Eurasian Economic Commission and Russian Federation legislation in 2022: their role and initial results.
  • The current situation as a need to update approaches to market regulation.
  • How to balance registration system under condition to speed up the introduction of cutting-edge solutions to the market?
16:00 – 17:30
Closed meeting room

Financing the health system: general issues

  • Budget situation as of autumn 2022 and the effectiveness of the current funding model.
  • How adequate is the health care financing system in the context of In the context of sanctions?
  • What actions should be taken to create the conditions for the development of industry and infrastructure, and the provision of medical care?
16:00 – 17:30
Lecture Hall 1
17:30 – 17:50

Coffee break

17:50 – 19:20
The Great Hall

New solutions in health care:
digitalization and high technologies as a way to optimization

  • Digital industry: business view.
  • Experience of Experimental Legal Regime application, further development of institutions
    supporting digitalization.
  • RWE/RWD application under sanctions.
  • New technological solutions as a way to reduce the burden on health care infrastructure and budgets.
  • What high tech diagnostics do we need for Russian health care to be more cost effective?
  • «Digital» PPP: applicability and what is the future in the industry?
17:50 – 19:20
Small Hall

International cooperation

  • Technology transfer.
  • “Will foreign countries help us”? Cooperation in science and production.
  • How can the government help business in supporting international cooperation and export?
  • What will the map of international cooperation in this direction look like in the current situation?
  • Are there points of convergence and collaboration with the PRC, India, Iran, South America, SEA and others?
17:50 – 19:20
Closed meeting room

The role of civil society institutions in healthcare system transformation

  • The changing role of civil society institutions, especially non-profit organizations under the new circumstances.
  • Formation of effective interaction between non-profit organizations, health care organizers and regulators for the implementation of transformation processes in the national healthcare.
  • Analysis of applied practices of NPO participation in the systemic changes in healthcare.
17:50 – 19:20
Lecture Hall 1

День 2

День 3

День 4

День 5

День 6

День 7

День 8

День 9

День 10


Что нужно изменить в регулировании CAR-T-технологий
Павел Волчков: «Регулятор редко говорит нет генотерапевтическим препаратам»
Как регулируются генетические данные в России
COVID отнимает у человека минимум полгода жизни
Партнерство государства и бизнеса в области создания инфраструктуры для биотехнологических разработок
Открыта продажа билетов на благотворительный концерт «Право на помощь»
Лев Амбиндер: «Мы развиваем в России высокотехнологичную медицину»


Александр Быков
Директор по экономике здравоохранения ГК «Р-Фарм»
Гагик Галстян
Президент «Российской диабетической ассоциации»
Роман Иванов
Проректор по научно-технологическому развитию университета «Сириус»
Виталий Омельяновский
Директор ФГБУ «Центр экспертизы и контроля качества медицинской помощи» Минздрава России
Евгений Шилов
Главный внештатный специалист нефролог Минздрава России
Марина Шестакова
Заместитель директора ФГБУ «НМИЦ эндокринологии» Минздрава России
Антон Данилов-Данильян
Сопредседатель общероссийской общественной организации «Деловая Россия»
Наталья Мантурова
Главный внештатный специалист пластический хирург Минздрава России
Олег Янушевич
Главный внештатный стоматолог Минздрава России
Владимир Гераскин
Основатель компании DMG
Павел Богомолов
Главный внештатный специалист гепатолог Минздрава Московской области
Илья Фридман
Со-основатель СРО «Медицинский союз Единство»
Наталия Анисимова
Президент Российской ассоциации обезболивания и безопасной стоматологии
Дмитрий Ахтуба
Председатель Комитета по медицине и организации здравоохранения МРО «Деловая Россия»
Александр Румянцев
Член Комитета по охране здоровья Государственной Думы Федерального Собрания Российской Федерации
Александр Терентьев
Директор СРО «Национальная ассоциация клиник эстетической медицины» (НАКЭМ)
Иван Барсола
Исполнительный директор дирекции по ESG ПАО «Сбербанк»
Дмитрий Кузнецов
Вице-президент Всероссийского союза страховщиков

Фото и видео

Запись трансляции конгресса «Право на здоровье» 20 октября 2022 г. Малый зал
Запись трансляции конгресса «Право на здоровье» 20 октября 2022 г. Большой зал
Right to Health Congress 2021 Video Summary
Photos of the 2021 Right to Health Congress


Young and dynamic Russian PR-agency.
DNA areas of focus:

  • classic PR
  • special projects
  • digital

Научный организатор

Legal support for the Congress. DENTONS is the world’s largest law firm providing a full range client services in more than 75 countries.

Деятельность ФГУБ «ЦЭККМП» Минздрава России охватывает широкий спектр вопросов, касающихся здравоохранения:
• организация, управление и финансирование
• экспертиза и контроль качества медицинской помощи
• оценка технологий здравоохранения и цифровизация

DENTONS provides legal services to international and Russian corporations, banks and other financial institutions, private equity funds, state enterprises and non-profit organizations.
The healthcare industry is one of the company’s priorities.

Право на помощь

Открыта продажа билетов на благотворительный концерт «Право на помощь»
На благотворительном концерте «Право на помощь» собрали 2,7 млн рублей для детской больницы
Золотая середина благотворительности


Digital Business Space
Pokrovka str., 47